乘聯會:中國11月狹義乘用車銷量減少4.1% 連跌五個月
據乘聯會數據顯示,11月全國乘用車市場零售銷量193.7萬台,按年下降4.1%,連跌五個月。廣義乘用車(轎車+MPV+SUV+微客)零售銷量196.62萬輛,按年亦下滑4.2%。
今年首十一個月,狹義乘用車零售按年下降7.9%至1,856.3萬輛。
新能源汽車方面,11月新能源乘用車批發銷量為7.9萬輛,按年下降41.7%,按月增長15%。
對於12月全國乘用車市場的展望,乘聯會秘書長崔東樹表示,春節前的消費是首購用戶的集中爆發期,車市表現必然較強。不過,明年農曆春節在陽曆1月,或導致1月廠家銷量開門紅壓力很大,但開門紅對全年的銷量提振效果較強,因此12月的產銷會相對克制。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.